NEUROENDOCRINE CARCINOMAS
Clinical trials for NEUROENDOCRINE CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: experimental drug ADCT-701 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in adults with rare cancers like neuroendocrine tumors, adrenal cancer, and malignant peripheral nerve sheath tumors. The goal is to find the safest dose and see if it can shrink tumors or slow disease. Participants receive …
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets Hard-to-Treat lung cancer in early trial
Disease control Recruiting nowThis study tests a new drug called IDE849, alone or with other drugs, in people with cancers that have a protein called DLL3, including small cell lung cancer. The trial has two phases and aims to see if the drug is safe and shrinks tumors. About 208 participants who have already…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC